glipizide and canagliflozin

glipizide has been researched along with canagliflozin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Forst, T; Rosak, C	1
Fralick, M; Gagne, JJ; Kesselheim, AS; Levin, R; Patorno, E	1

Reviews

1 review(s) available for glipizide and canagliflozin

Article	Year
[Glycosuria with SGLT-2 inhibitors--a new treatment approach for type 2 diabetes mellitus]. MMW Fortschritte der Medizin, 2012, Dec-17, Volume: 154 Suppl 4 Topics: Benzhydryl Compounds; Canagliflozin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Follow-Up Studies; Glipizide; Glucosides; Glycosuria; Humans; Hypoglycemic Agents; Kidney Tubules, Proximal; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes	2012

Article

Year

[Glycosuria with SGLT-2 inhibitors--a new treatment approach for type 2 diabetes mellitus].

MMW Fortschritte der Medizin, 2012, Dec-17, Volume: 154 Suppl 4

Topics: Benzhydryl Compounds; Canagliflozin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Follow-Up Studies; Glipizide; Glucosides; Glycosuria; Humans; Hypoglycemic Agents; Kidney Tubules, Proximal; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes

2012

Other Studies

1 other study(ies) available for glipizide and canagliflozin

Article	Year
Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes Medications. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2020, Volume: 23, Issue:4 Topics: Aged; Canagliflozin; Cohort Studies; Contracts; Diabetes Mellitus, Type 2; Exenatide; Female; Follow-Up Studies; Glipizide; Glucagon-Like Peptides; Humans; Hypoglycemic Agents; Immunoglobulin Fc Fragments; Male; Middle Aged; Outcome Assessment, Health Care; Recombinant Fusion Proteins; Sitagliptin Phosphate	2020

Article

Year

Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes Medications.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2020, Volume: 23, Issue:4

Topics: Aged; Canagliflozin; Cohort Studies; Contracts; Diabetes Mellitus, Type 2; Exenatide; Female; Follow-Up Studies; Glipizide; Glucagon-Like Peptides; Humans; Hypoglycemic Agents; Immunoglobulin Fc Fragments; Male; Middle Aged; Outcome Assessment, Health Care; Recombinant Fusion Proteins; Sitagliptin Phosphate

2020